CURRENT TRENDS IN INTERNATIONAL MERGERS AND ACQUISITIONS OF PHARMACEUTICAL COMPANIES
https://doi.org/10.21686/2410-7395-2021-2-97-108
Abstract
The article analyzes the results of mergers and acquisitions of global pharmaceutical companies and their impact on the global pharmaceutical industry. The relevance of this research is determined by the high significance of mergers and acquisitions of global pharmaceutical companies on the global pharmaceutical industry and market. A comprehensive approach is used to assess the impact of mergers and acquisitions of pharmaceutical companies on the global pharmaceutical industry. The article presents statistical data on the volume and number of venture investments in the pharmaceutical and biotechnological industries. The reasons for mergers and acquisitions by pharmaceutical companies, as well as the dynamics of the activity of such transactions, are determined. The geographical structure of stock transactions and the total number of mergers and acquisitions of pharmaceutical companies are presented, as well as examples of the largest mergers and acquisitions of pharmaceutical companies.
About the Author
Yana S. Sinitsova
Polytechnic University of Saint Petersburg of Peter the Great
Russian Federation
Russian Federation
Yana S. Sinitsova, Post-Graduate Student
29 Polytechnic Street, Saint Petersburg, 195251
References
1. Volodin S. N., Zueva E. S. Vliyanie sdelok sliyaniya i pogloshcheniya na tseny aktsiy farmatsevticheskikh kompaniy [Impact of Mergers and Acquisitions on Pharmaceutical Companies ' Share Prices] Audit i finansovyy analiz, 2017, No. 5, pp. 98–102. (In Russ.). DOI: https://auditfin.com/fin/2017/5-6/fin_2017_51_61_rus_03_02.pdf
2. Gokhan Patrik A. Sliyaniya, pogloshcheniya i restrukturizatsiya kompaniy [Mergers, Acquisitions and Corporate Restructuring], translated from English. 4th ed. Moscow, Alpina Pablisherz, 2010. (In Russ.).
3. Dmitrik E. Kak M&A menyayut rasstanovku sil na mirovoy farmatsevticheskoy arene? [How are M&A Changing the Balance of Power on the Global Pharmaceutical Scene?], Ezhenedelnik Apteka, 2018, No. 49 (1 170). (In Russ.). DOI: https://www.apteka.ua/article/480888
4. Dmitrik E. Uspekhi i neudachi mirovoy farmindustrii v 2018 g. [Successes and Failures of the Global Pharmaceutical Industry in 2018], Ezhenedelnik Apteka, 2019, No. 20 (1 191). (In Russ.). DOI: https://www.apteka.ua/article/502313
5. Kosmin A. D., Kuznetsova O. P., Sinitsova Ya. S. Problemy obes-pecheniya naseleniya kachestvennymi lekarstvennymi sredstvami i farmatsevticheskimi substantsiyami [Problems of Providing the Population with High-Quality Medicines and Pharmaceutical Substances]. Omsk, 2017. (In Russ.).
6. Polyakova E. 1Q 2020 Farmatsevtika i zdravookhranenie [1Q 2020 Pharmaceuticals and Healthcare]. (In Russ.). Available at: https://www.capital-times.com/1q-2020-pharmacy (accessed 05.02.2021).
7. Sinitsova Ya. S. Rol farmatsevticheskoy industrii v mirovoy ekonomike [The Role of the Pharmaceutical Industry in the Global Economy], Vestnik Samarskogo gosudarstvennogo ekonomicheskogo universiteta, 2020, No. 2 (184), pp. 9–12. (In Russ.).
8. Amgen to Acquire Otezla for $13,4 Billion in Cash or Approximately $11,2 Billion Net of Anticipated Future Cash Tax Benefits. Amgen, Inc, 2020. DOI: https://www.amgen.com/media/news-releases/2019/08/amgen-toacquire-otezla-for-134-billion-in-cash-or-approximately-112-billion-net-ofanticipated-future-cash-tax-benefits/
9. Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a Leading Biopharma Company, BMS Newsroom, 2020. DOI: https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibbcompletes-acquisition-celgene-creating-le#:~:text=NEW%20YORK--(BUSINESS% 20WIRE,April%2012%2C%202019%2C%20approval%20by.
10. Takeda Completes Acquisition of Shire, Becoming a Global, Values-based, R&D-Driven Biopharmaceutical Leader. Takeda, 2020. DOI: https://www.takeda.com/newsroom/newsreleases/2019/takedacompletes-acquisition-of-shire-becoming-a-global-values-based-rd-drivenbiopharmaceutical-leader/
11. Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21,4 Billion. Danaher Corporation Investors, 2019. DOI: https://investors.danaher.com/2019-02-25-Danaher-to-Acquire-the-BiopharmaBusiness-of-General-Electric-Life-Sciences-for-21-4-Billion#:~:text=25%2C%202019%20%2FPRNewswire%2F%20--,purchase%20price%20of%20approximately%20%2421.4.
12. Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World's Need for Medicine. Cision, 2020. DOI: https://www.prnewswire.com/newsreleases/mylan-and-upjohn-a-division-of-pfizer-to-combine-creating-a-newchampion-for-global-health-uniquely-positioned-to-fulfill-the-worlds-needfor-medicine-300892146.html.
13. Pfizer to Acquire Array BioPharma. Pfizer, 2020. DOI: https:// www.pfizer.com/news/press-release/press-release-detail/pfizer_to_acquire _array_biopharma.
14. Novartis to Acquire the Medicines Company for USD 9.7 bn, Adding Inclisiran, a Potentially Transformational Investigational CholesterolLowering Therapy to Address Leading Global Cause of Death. Novartis, 2020. DOI: https://www.novartis.com/news/media-releases/novartis-acquiremedicines-company-usd-97-bn-adding-inclisiran-potentiallytransformational-investigational-cholesterol-lowering-therapy-addressleading-global.
15. Lilly Announces Agreement to Acquire Loxo Oncology. Eli Lilly and Company, 2020. DOI: https://investor.lilly.com/news-releases/newsrelease-details/lilly-announces-agreement-acquire-loxo-oncology.
16. GSK Completes Acquisition of TESARO, an Oncology Focused Biopharmaceutical Company. GSK, 2020. DOI: https://www.gsk.com/engb/media/press-releases/gsk-completes-acquisition-of-tesaro-an-oncologyfocused-biopharmaceutical-company/
Review
For citations:
Sinitsova Ya.S. CURRENT TRENDS IN INTERNATIONAL MERGERS AND ACQUISITIONS OF PHARMACEUTICAL COMPANIES. International Trade and Trade Policy. 2021;7(2):97-108. (In Russ.) https://doi.org/10.21686/2410-7395-2021-2-97-108
Views:
527
Email this article 
